VenatoRx Pharmaceuticals, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Malvern PA United States (2010)

Organization Overview

First Clinical Trial
2016
NCT02955459
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Venatorx Pharmaceuticals, Inc. | VenatoRx Pharmaceuticals, Inc.